ICN Raises $50 Million - Los Angeles Times
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
COSTA MESA — ICN Pharmaceuticals Inc. said it privately sold $50 million in preferred stock to fund acquisitions in the U.S., Eastern Europe and Asia. The drug company said the purchases
could eventually add more than $150 million in annual sales. Last year, the company posted sales of about $500 million. The new issue of preferred stock pays a 6% annual dividend in cash or
stock, and is convertible into common shares. MORE TO READ